Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTH | P32929 | 2/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.39 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.39 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3054023 | 0.98 | CTH (0.45) | CTHAGTR1POLBKDM4EMAPT | |
| SCHEMBL27111195 | 0.92 | CTH (0.44) | CTHAGTR1KDM4EMAPTTDP1 | |
| SCHEMBL20150968 | 0.91 | CTH (0.40) | CTHAGTR1POLBKDM4EMAPT | |
| SCHEMBL5066364 | 0.89 | CTH (0.41) | CTHAGTR1KDM4EMAPTTDP1 | |
| SCHEMBL5066363 | 0.89 | CTH (0.41) | CTHAGTR1KDM4EMAPTTDP1 | |
| SCHEMBL9743902 | 0.89 | CTH (0.62) | CTHAGTR1POLBKDM4EMAPT | |
| SCHEMBL13826725 | 0.81 | KDM4E (0.52) | CTHAGTR1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL13826735 | 0.81 | POLB (0.61) | CTHPOLBKDM4EMAPTLMNA | |
| SCHEMBL20148185 | 0.81 | CTH (0.36) | CTHKDM4EMAPTMEN1KMT2A | |
| SCHEMBL4100134 | 0.81 | NPC1 (0.59) | CTHAGTR1KDM4EMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067860-A1 | COMPOSITIONS AND METHODS FOR CARBON DIOXIDE SOLIDIFICATION | CHEVRON U.S.A. INC. | 2024-02-29 | — | — | US | disclosed |
| US-20240067860-A1 | COMPOSITIONS AND METHODS FOR CARBON DIOXIDE SOLIDIFICATION | CHEVRON U.S.A. INC. | 2024-02-29 | — | — | US | disclosed |
| US-10633332-B2 | Guanidine compounds for removal of oxyanions from aqueous solutions and for carbon dioxide capture | UT-BATTELLE, LLC (US) | 2020-04-28 | — | — | US | disclosed |
| US-20180134655-A1 | GUANIDINE COMPOUNDS FOR REMOVAL OF OXYANIONS FROM AQUEOUS SOLUTIONS AND FOR CARBON DIOXIDE CAPTURE | U.S. DEPARTMENT OF ENERGY | 2018-05-17 | — | — | US | disclosed |
| US-20180134655-A1 | GUANIDINE COMPOUNDS FOR REMOVAL OF OXYANIONS FROM AQUEOUS SOLUTIONS AND FOR CARBON DIOXIDE CAPTURE | U.S. DEPARTMENT OF ENERGY | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10633332-B2 | Guanidine compounds for removal of oxyanions from aqueous solutions and for carbon dioxide capture | GUCY1A1, GUCY1A2, GUCY1B1 | CTH 1990/4885AGTR1 1538/4885POLB 343/4885 |
| US-20180134655-A1 | GUANIDINE COMPOUNDS FOR REMOVAL OF OXYANIONS FROM AQUEOUS SOLUTIONS AND FOR CARBON DIOXIDE CAPTURE | GUCY1A1, GUCY1A2, GUCY1B1 | CTH 1990/4885AGTR1 1538/4885POLB 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.